相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Yin-yang activities and vicious cycles in the tumor microenvironment
Isaac P. Witz
CANCER RESEARCH (2008)
The chemokine network in systemic lupus erythematous nephritis
Brad H. Rovin
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells
C. A. Hamill et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus
Zeguo Zhao et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma
George S. Watts et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment
Dominique B. Hoelzinger et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
A new class of reverse signaling costimulators belongs to the TNF family
Mingyi Sun et al.
JOURNAL OF IMMUNOLOGY (2007)
Molecular biology of bone metastasis
Lauren A. Kingsley et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates
David Gius et al.
CANCER RESEARCH (2007)
Early diversification of the TNF superfamily in teleosts: Genomic characterization and expression analysis
Gavin W. Glenney et al.
JOURNAL OF IMMUNOLOGY (2007)
A previously unrecognized protein-protein interaction between TWEAK and CD163:: Potential biological implications
Laura C. Bover et al.
JOURNAL OF IMMUNOLOGY (2007)
Cytokines in the pathogenesis of rheumatoid arthritis
Iain B. McInnes et al.
NATURE REVIEWS IMMUNOLOGY (2007)
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine
Charu Dogra et al.
FASEB JOURNAL (2007)
Metastasis: recent discoveries and novel treatment strategies
Suzanne A. Eccles et al.
LANCET (2007)
Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes - Evidence for tweak- independent functions of Fn14 during myogenesis
Charu Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia
Xiaohui Zhang et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Role of TWEAK and Fn14 in tumor biology
Jeffrey A. Winkles et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Inflammation in wound repair: Molecular and cellular mechanisms
Sabine A. Eming et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Beyond I kappa Bs: alternative regulation of NF-kappa B activity
Manfred Neumann et al.
FASEB JOURNAL (2007)
TWEAK and the central nervous system
Manuel Yepes
MOLECULAR NEUROBIOLOGY (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications
J. Marc Simard et al.
LANCET NEUROLOGY (2007)
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
Mahasweta Girgenrath et al.
EMBO JOURNAL (2006)
Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases
Manuel Yepes et al.
DRUG NEWS & PERSPECTIVES (2006)
Urinary TWEAK and the activity of lupus nephritis
Noa Schwartz et al.
JOURNAL OF AUTOIMMUNITY (2006)
Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts
Y. Hosokawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions
Christopher W. Borysenko et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Cytokine cooperation in renal tubular cell injury: The role of TWEAK
P. Justo et al.
KIDNEY INTERNATIONAL (2006)
Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis
Koichi Kamata et al.
JOURNAL OF IMMUNOLOGY (2006)
NF-κB and the immune response
M. S. Hayden et al.
ONCOGENE (2006)
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome
Nhan L. Tran et al.
CANCER RESEARCH (2006)
Intraovarian tumor necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible-14 ligand-receptor system limits ovarian preovulatory follicles from excessive luteinization
Ananya De et al.
MOLECULAR ENDOCRINOLOGY (2006)
TWEAK is a novel arthritogenic mediator
Stuart J. Perper et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques -: Modulation by atorvastatin
Begona Munoz-Garcia et al.
STROKE (2006)
TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules
Sharron A. N. Brown et al.
BIOCHEMICAL JOURNAL (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human
Claudia Bossen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein
C Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TWEAK and Fn14: New molecular targets for cancer therapy?
JA Winkles et al.
CANCER LETTERS (2006)
Inflammation, a key event in cancer development
HT Lu et al.
MOLECULAR CANCER RESEARCH (2006)
Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue.: Relationship with other inflammatory cytokines in obesity
MR Chacón et al.
CYTOKINE (2006)
Proinflammatory effects of Tweak/Fn14 interactions in glomerular mesangial cells
S Campbell et al.
JOURNAL OF IMMUNOLOGY (2006)
IKK beta/2 induces TWEAK and apoptosis in mammary epithelial cells
Fiona O. Baxter et al.
DEVELOPMENT (2006)
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis
S. Wang et al.
ONCOGENE (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells
Takashi Ando et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Inflammation in stroke and focal cerebral ischemia
Judy Huang et al.
SURGICAL NEUROLOGY (2006)
TWEAK attenuates the transition from innate to adaptive immunity
H Maecker et al.
CELL (2005)
Immune cell migration in inflammation: present and future therapeutic targets
AD Luster et al.
NATURE IMMUNOLOGY (2005)
Tumor inflammatory angiogenesis and its chemoprevention
A Albini et al.
CANCER RESEARCH (2005)
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-κB pathway activation
R Polavarapu et al.
JOURNAL OF NEUROSCIENCE (2005)
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis
S Desplat-Jégo et al.
CLINICAL IMMUNOLOGY (2005)
TWEAK induces liver progenitor cell proliferation
A Jakubowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis
N Felli et al.
JOURNAL OF IMMUNOLOGY (2005)
TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage
Y Kaduka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Tweak induces mammary epithelial branching morphogenesis
JS Michaelson et al.
ONCOGENE (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs
J Hauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression
NL Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A soluble fn14-fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia
M Yepes et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis
AM Mueller et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes
L Jin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages
SH Kim et al.
CIRCULATION JOURNAL (2004)
Cytokine-receptor pairing: Accelerating discovery of cytokine function
D Foster et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation
M Fotin-Mleczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration
I Potrovita et al.
JOURNAL OF NEUROSCIENCE (2004)
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity
S Campbell et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice
DH Ho et al.
CANCER RESEARCH (2004)
Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling
K Almstrup et al.
CANCER RESEARCH (2004)
Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis
T Kawakita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Cellular and molecular regulation of muscle regeneration
SBP Charge et al.
PHYSIOLOGICAL REVIEWS (2004)
Switching mature retinal ganglion cells to a robust growth state in vivo:: Gene expression and synergy with RhoA inactivation
D Fischer et al.
JOURNAL OF NEUROSCIENCE (2004)
TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF
HR Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Involvement of GSK-3β in TWEAK-mediated NF-κB activation
A De Ketelaere et al.
FEBS LETTERS (2004)
Molecular basis of angiogenesis and cancer
T Tonini et al.
ONCOGENE (2003)
TWEAK induces NF-κB2 p100 processing and long lasting NF-κB activation
T Saitoh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR - Evidence for a second TWEAK receptor
TC Polek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies
M Nakayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-κB through TNF receptor-associated factors
SY Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor
SR Wiley et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
The Fn14 cytoplasmic tall binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-κB activation
SAN Brown et al.
BIOCHEMICAL JOURNAL (2003)
The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors
NL Tran et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity
PJ Donohue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2003)
The CD95(APO-1/Fas) DISC and beyond
ME Peter et al.
CELL DEATH AND DIFFERENTIATION (2003)
TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-κB activation and IL-10 production
LG Xu et al.
JOURNAL OF IMMUNOLOGY (2002)
Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells
N Harada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis
CA Wilson et al.
CELL DEATH AND DIFFERENTIATION (2002)
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity
S Desplat-Jégo et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells
MJ Kaplan et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease
MN Sack
PHARMACOLOGY & THERAPEUTICS (2002)
Multiple pathways of TWEAK-Induced cell death
M Nakayama et al.
JOURNAL OF IMMUNOLOGY (2002)
Angiogenesis in rheumatoid arthritis
Ewa M. Paleolog
ARTHRITIS RESEARCH & THERAPY (2002)
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
Y Chicheportiche et al.
ARTHRITIS RESEARCH (2002)
The molecular architecture of the TNF superfamily
JL Bodmer et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
SR Wiley et al.
IMMUNITY (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies
Y Chicheportiche et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)
A Kaptein et al.
FEBS LETTERS (2000)
Involvement of TWEAK in interferon γ-stimulated monocyte cytotoxicity
M Nakayama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages
MJ Kaplan et al.
JOURNAL OF IMMUNOLOGY (2000)
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas
SLY Feng et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent
GJ Inman et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
